1 – 27 of 27
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma
(
- Contribution to journal › Article
-
Mark
EUFOREA/EPOS2020 statement on the clinical considerations for CRSwNP care
(
- Contribution to journal › Article
- 2023
-
Mark
Eosinophils—from cradle to grave
(
- Contribution to journal › Article
-
Mark
Biologics in severe asthma : A pragmatic approach for choosing the right treatment for the right patient
(
- Contribution to journal › Article
-
Mark
Impact of Inititing Biologics in Patients With Severe Asthma on Long-term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry
(
- Contribution to journal › Article
-
Mark
Identifying Predictors of First-Line Subcutaneous TNF-Inhibitor Persistence in Patients with Inflammatory Arthritis : A Decision Tree Analysis by Indication
(
- Contribution to journal › Article
-
Mark
Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both
(
- Contribution to journal › Article
-
Mark
Is asthma's heterogeneity too vast to use traditional phenotyping for modern biologic therapies?
(
- Contribution to journal › Article
- 2022
-
Mark
Health-Care and Societal Costs Associated with Non-Persistence with Subcutaneous TNF-α Inhibitors in the Treatment of Inflammatory Arthritis (IA) : A Retrospective Observational Study
(
- Contribution to journal › Article
-
Mark
Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic Therapy
(
- Contribution to journal › Article
-
Mark
Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis
(
- Contribution to journal › Article
- 2021
-
Mark
Capturing biologic treatment for IBD in the Swedish Prescribed Drug Register and the Swedish National Patient Register–a validation study
(
- Contribution to journal › Article
- 2019
-
Mark
EUFOREA consensus on biologics for CRSwNP with or without asthma
(
- Contribution to journal › Scientific review
-
Mark
Secukinumab efficacy on resolution of enthesitis in psoriatic arthritis : pooled analysis of two phase 3 studies
(
- Contribution to journal › Article
-
Mark
Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA : Results from the nationwide Swedish register
(
- Contribution to journal › Article
- 2018
-
Mark
Impact of Drug Induced Remission in Rheumatoid Arthritis
2018)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Targeting the interleukin-4 and interleukin-13 pathways in severe asthma : Current knowledge and future needs
(
- Contribution to journal › Scientific review
-
Mark
Towards precision medicine in severe asthma : Treatment algorithms based on treatable traits
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Role of biologics targeting type 2 airway inflammation in asthma : What have we learned so far?
(
- Contribution to journal › Scientific review
-
Mark
Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Patenting Human Genes in Europe: and how it compares to the US and Australia
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2016
-
Mark
Economic burden of psoriasis and potential cost offsets with biologic treatment : A swedish register analysis
(
- Contribution to journal › Article
- 2015
-
Mark
Resource Use in Patients with Psoriasis After the Introduction of Biologics in Sweden
(
- Contribution to journal › Article
- 2012
-
Mark
Targeting T cell migration in inflammatory bowel disease.
(
- Contribution to journal › Article
-
Mark
Assessing the Inventiveness of Bio-Pharmaceuticals under European and US Patent Law - A comparative study with special emphasis on DNA- and protein-related inventions
2012)(
- Thesis › Doctoral thesis (monograph)
- 2009
-
Mark
Characterization of Meteorin-An Evolutionary Conserved Neurotrophic Factor
(
- Contribution to journal › Article
- 2007
-
Mark
Trends in medication and health-related quality of life in a population-based rheumatoid arthritis register in Malmo, Sweden
(
- Contribution to journal › Article